clinical research

Overcoming Depression | Center for Conscious Living | Naperville, IL (630) 249-1983

Published May 23, 2013

Overcoming Depression | Center for Conscious Living | Naperville, IL (630) 249-1983 – Overcome Your Depression NOW! http://www.centerforconsciousliving.com/weight Learn Rational Emotive Behavior Therapy and Self-Hypnosis. Center for Conscious …

Do you know what killed Meriwether Lewis?
Peck gave… Continue reading →

A Clinical Treatment Intervention for Dysphoria: Externalizing Metaphors Therapy.

Published May 22, 2013

A Clinical Treatment Intervention for Dysphoria: Externalizing Metaphors Therapy.

Clin Psychol Psychother. 2013 May 20;
McGuinty E, Armstrong D, Carrière AM

The purpose of this article is to explore a novel, short-term treatment intervention for internalizing behaviours. This intervention… Continue reading →

Changes in Capacity to Consent Over Time in Patients Involved in Psychiatric Research.

Published May 11, 2013

Changes in capacity to consent over time in patients involved in psychiatric research.

Br J Psychiatry. 2013 May 9;
Palmer BW, Savla GN, Roesch SC, Jeste DV

BACKGROUND: Informed consent is a key element of ethical clinical research. Patients… Continue reading →

Mitochondrial Dysfunction, Oxidative Stress, and Major Depressive Disorder.

Published May 8, 2013

Mitochondrial dysfunction, oxidative stress, and major depressive disorder.

Neuropsychiatr Dis Treat. 2013; 9: 567-73
Tobe EH

There is controversy about depression being a physical illness, in part because a reproducible, sensitive, and specific biologic marker is not available. However,… Continue reading →

Can MDMA Play a Role in the Treatment of Substance Abuse?

Published May 1, 2013

Can MDMA Play a Role in the Treatment of Substance Abuse?

Curr Drug Abuse Rev. 2013 Apr 29;
Jerome L, Shira Schuster MA, Yazar-Klosinski BB

A wider array of treatments are needed for people with substance abuse disorders. Some… Continue reading →

Neurological Soft Signs in Individuals With Pathological Gambling.

Published April 18, 2013

Neurological Soft Signs in Individuals with Pathological Gambling.

PLoS One. 2013; 8(4): e60885
Elman I, Gurvits TV, Tschibelu E, Spring JD, Lasko NB, Pitman RK

Increased neurological soft signs (NSSs) have been found in a number of neuropsychiatric syndromes,… Continue reading →

Life-Threatening Rhabdomyolysis Following the Interaction of Two Commonly Prescribed Medications.

Published April 17, 2013

Life-threatening rhabdomyolysis following the interaction of two commonly prescribed medications.

Australas Med J. 2013; 6(3): 112-4
Fallah A, Deep M, Smallwood D, Hughes P

We report an interaction between erythromycin and simvastatin resulting in life-threatening rhabdomyolysis in an elderly… Continue reading →

Will the EU Clinical Trials Regulation Support the Innovative Industry in Bringing New Medicines Faster to Patients?

Published April 16, 2013

Will the EU Clinical Trials Regulation Support the Innovative Industry in Bringing New Medicines Faster to Patients?

Pharmaceut Med. 2013 Apr; 27(2): 75-82
Atzor S, Gokhale S, Doherty M

A perspective from the innovative industry is provided in this… Continue reading →

Associated With Intrathecal Baclofen Treatment and Duloxetine in Patients With Multiple Sclerosis.

Published April 13, 2013

Associated with intrathecal baclofen treatment and duloxetine in patients with multiple sclerosis.

Int J Immunopathol Pharmacol. 2012 Jan-Mar; 25(1 Suppl): 51S-56S
Ranieri M, Putignano P, Fiore P, Santamato A, Megna G, Bellomo RG, Cristella G, Saggini R, Megna M… Continue reading →

Systems Level Neuroplasticity in Drug Addiction.

Published April 13, 2013

Systems Level Neuroplasticity in Drug Addiction.

Cold Spring Harb Perspect Med. 2013 Apr 11;
Feltenstein MW, See RE

Drug addiction is a chronic relapsing disorder for which research has been dedicated to understand the various factors that contribute to… Continue reading →